HSBC MSCI Europe UCITS ETF (LON:HMES)
London · Delayed Price · Currency is GBP · Price in GBX | Assets | 55.50M |
| Expense Ratio | 0.10% |
| PE Ratio | n/a |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | -98.89% |
| Volume | 776 |
| Open | 18.02 |
| Previous Close | 18.05 |
| Day's Range | 18.02 - 18.10 |
| 52-Week Low | 17.75 |
| 52-Week High | 1,817.12 |
| Beta | n/a |
| Holdings | 440 |
| Inception Date | Jul 13, 2022 |
About HMES
HSBC MSCI Europe UCITS ETF is an exchange traded fund launched and managed by HSBC Global Asset Management (UK) Limited. The fund invests in the public equity markets of developed countries in Europe. It seeks to invest in the stocks of companies operating across diversified sectors. The fund invests in the stocks of large-cap and mid-cap companies. It seeks to replicate the performance of the MSCI Europe Index, by investing in the stocks of companies as per their weightings in the index. The fund was formerly known as HSBC ETFs Public Limited Company - HSBC MSCI Europe ETF. HSBC MSCI Europe UCITS ETF was formed on June 1, 2010 and is domiciled in Ireland.
Performance
HMES had a total return of -98.89% in the past year, including dividends. Since the fund's inception, the average annual return has been -75.22%.
Top 10 Holdings
35.09% of assets| Name | Symbol | Weight |
|---|---|---|
| Capital Cash Ctrl | n/a | 17.67% |
| SAP SE | SAP | 2.47% |
| ASML Holding N.V. | ASML | 2.47% |
| Nestlé S.A. | NESN | 1.98% |
| Novartis AG | NOVN | 1.80% |
| MSCI Europe Index Net Total Return Future Sept 25 | ZRPU5 | 1.79% |
| Roche Holding AG | ROG | 1.77% |
| Novo Nordisk A/S | NOVO.B | 1.74% |
| AstraZeneca PLC | AZN | 1.71% |
| HSBC Holdings plc | HSBA | 1.70% |